Celgene Corp (CELG :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
CELG FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
-
-
Final Glance: Biotechnology companies 17 May 2013 - The Associated Press
-
-
Midday Glance: Biotechnology companies 17 May 2013 - The Associated Press
-
Early Glance: Biotechnology companies 17 May 2013 - The Associated Press
-
Final Glance: Biotechnology companies 16 May 2013 - The Associated Press
-
-
Midday Glance: Biotechnology companies 16 May 2013 - The Associated Press
-
Early Glance: Biotechnology companies 16 May 2013 - The Associated Press
-
Final Glance: Biotechnology companies 15 May 2013 - The Associated Press
MORE FROM CNBC
-
-
-
-
-
Jim Cramer's 5 Investing Sweet Spots 14 May 2013 - CNBC.com
-
-
-
-
MORE FROM OUR PARTNERS
-
Celgene: Apremilast For Psoriatic Arthritis Offers Upside 14 May 2013 - Seeking Alpha
-
Part 2: Will Array BioPharma Become A Late-Stage Biopharmaceutical Com... 12 May 2013 - Seeking Alpha
-
Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Com... 12 May 2013 - Seeking Alpha
-
Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Ar... 09 May 2013 - Seeking Alpha
-
Cramer's Mad Money - 10 Things To Watch In The Week Ahead (5/3/13) 05 May 2013 - Seeking Alpha
-
Biotechnology: Strong Fundamentals Are The Basis Of Strong Performance 03 May 2013 - Seeking Alpha
-
Biotech Bulls Can Ignore The Warning Signs At Their Peril 02 May 2013 - Seeking Alpha
-
Cramer's Mad Money - 16 Things To Watch In The Week Ahead (4/26/13) 28 Apr 2013 - Seeking Alpha
-
Cramer's Mad Money - Sinclair's Remarkable Transformation (4/26/13) 28 Apr 2013 - Seeking Alpha
-
Cramer's Mad Money - Why Analysts Were Wrong About Microsoft (4/25/13) 26 Apr 2013 - Seeking Alpha
LATEST TRANSCRIPTS
-
Celgene's CEO Discusses Q1 2012 Results - Earnings Call Transcript 25 Apr 2013 - Seeking Alpha
PRESS RELEASES
-
AnaptysBio Awarded U.S. Government Contract To Develop Anti-Ricin Anti... 16 May 2013 - PR Newswire
-
In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimisti... 14 May 2013 - PR Newswire
-
Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled(TM) D... 14 May 2013 - Business Wire
-
Cyclacel Reports First Quarter 2013 Financial Results 13 May 2013 - Globe Newswire
-
Research and Markets: Hematology Partnering Terms and Agreements - 201... 10 May 2013 - Business Wire
-
Research and Markets: Bacterial Partnering Terms and Agreements - 2013... 10 May 2013 - Business Wire
-
Research and Markets: The Corporate Reputation of Pharma in 2012: The ... 10 May 2013 - Business Wire
-
Acceleron's ACE-536 Preclinical Data Presentation Selected for Best Ab... 10 May 2013 - Business Wire
-
VIDEO RELEASE -- Galena Biopharma Reports First Quarter 2013 Financial... 09 May 2013 - Globe Newswire
-
Over 700 Attend Annual Multiple Myeloma Research Foundation (MMRF) Lau... 09 May 2013 - Business Wire
